- Global Pharma News & Resources

Whole Genome & Exome Sequencing - Global Markets (2018-2022) by Research, Clinical, Direct to Consumer, AgriBio & Tumor Including Test Price and Volume Forecasts with Executive and Consultant Guides -

The "Whole Genome and Exome Sequencing Markets by Research, Clinical, Direct to Consumer, AgriBio & Tumor Including Test Price and Volume Forecasts with Executive and Consultant Guides 2018 to 2022" report has been added to's offering.

A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.

The report forecasts the market size out to 2022. The report includes detailed breakouts for 14 countries and 5 regions.

Market Dynamics

Factors Driving Growth

  • Diagnostic Factors
  • Interpreting the Code Otherwise
  • Changes in Agriculture
  • Fertility Technology Comes of Age
  • Pathogen Challenges

Factors Limiting Growth

  • Increased Competition Lowers Price
  • Lower Costs
  • Healthcare Cost Concerns Curtail Growth
  • Wellness Has a Downside
  • GMO Opposition Movement
Recent Developments
  • Australian Newborn WES Project
  • Human Longevity Launches Whole Genome Product, MassMutual Partnerships
  • Influence of Whole Genome Sequencing growing
  • Rady Children's and Edico Genome Extend WGS Collaboration
  • $1500 to sequence newborns in China
  • Newborns to Get Whole Genome Sequencing
  • Eurofins Acquiring PerkinElmer's NTD Laboratory Services Business
  • Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
  • AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
  • The Cooper Companies' Women's Health Care Unit Acquires Genesis Genetics
  • Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A)
  • New Investments in to Boost DNA Business
  • GHO Capital Announces Acquisition of DNA Diagnostics Center
  • PerkinElmer Launches Clinical Whole Genome Sequencing Services
  • and more...

Key Topics Covered

1. Introduction and Market Definition

2. Market Overview

3. Market Trends

4. WGES Recent Developments

5. Country Market Sizes - North America

6. Country Markets - Europe

7. Country Markets - Asia Pacific

8. Country Markets - Latin America, Africa & The Middle East

9. Global Market Summary

10. Vision of the Future of Whole Genome Sequencing

Companies Profiled

  • 10X Genomics
  • 23 and Me
  • Agilent Technologies
  • BGI Genomics Co. Ltd.
  • Bio-Rad
  • Centogene
  • Complete Genomics - BGI
  • Dante Labs
  • Fabric Genomics
  • GE Global Research
  • Gencove
  • Gene by Gene Ltd.
  • Genewiz
  • Grail
  • Guardiome
  • Helix
  • Human Longevity, Inc.
  • Illumina
  • Invitae
  • Novogene
  • Omega Bioservices
  • ORIG3N
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Perkin Elmer
  • Qiagen
  • Regeneron
  • Roche Molecular Diagnostics
  • Siemens Healthcare
  • Sure Genomics
  • Thermo Fisher
  • Veritas Genetics
  • and more...

For more information about this report visit

View source version on

Editor Details

Last Updated: 08-Nov-2018